Indivior PLC enters new employment agreements with CFO Ryan Preblick; no changes to compensation or role

Indivior Pharmaceuticals, Inc.

New employment agreement for CFO Ryan Preblick, effective Jan 1, 2025, aligns with current U.S. executive forms.
No changes to compensation, responsibilities, or title from prior 2020 agreement.
Annual base salary remains $558,819; cash bonus target at 60% of base salary (max 120%).
LTIP annual award anticipated at 400% of base salary, subject to Compensation Committee discretion.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.